CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian...
Phase 3
Salt Lake City, Utah, United States and 207 other locations
liposomal doxorubicin (PLD), and to compare the efficacy and safety of NP-G2-044+PLD vs. PLD alone in participants with platinum-resistant ovarian...
Phase 2, Phase 3
Salt Lake City, Utah, United States and 5 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Salt Lake City, Utah, United States and 213 other locations
Ovarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV90 ...
Phase 1
West Valley City, Utah, United States and 16 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Murray, Utah, United States and 106 other locations
Researchers are looking for other ways to treat high-grade serous and certain other ovarian cancer. High-grade means the cancer...
Phase 1, Phase 2
West Valley City, Utah, United States and 32 other locations
(PFS) in women with high-grade, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, expressing hig...
Phase 3
Salt Lake City, Utah, United States and 298 other locations
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer...
Phase 3
Ogden, Utah, United States of America and 139 other locations
female participants with recurrent or difficult to treat epithelial ovarian, primary peritoneal or fallopian tube cancer.This study...
Phase 1
Salt Lake City, Utah, United States and 4 other locations
This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...
Phase 2
Salt Lake City, Utah, United States and 73 other locations
Clinical trials
Research sites
Resources
Legal